Muscular Endurance Delays Muscle Fatigue CarnoSyn - Carnosine Synthesizer A Dietary Supplement Informed Sport - We Test, You Trust Steroid Free Vegan Kosher

Buy Bare Performance Nutrition BPN Flight Pre Workout, Supports Energy and Mental Focus, Improved Endurance & Muscle Pumps with CarnoSyn® Beta Alanine, Blue Raspberry, 30 Servings on Amazon.com ✓ FREE...

Best Pre-Workout for Stress Relief EBOOST Pow Pre-Workout All ratings are determined solely by our editorial team. Cost per serving: $1.65 Caffeine per serving: 175 milligrams Noteworthy ingredients: CarnoSyn beta-alanine, N-acetyl L-tyrosine, organic beet root powder, calcium fructoborate, L-theanine, caffeine, dimethylaminoethanol, 5-hydroxytryptophan Flavors available: Blue raspberry, tropical punch and berry melon Certifications: None Better Business Bureau (BBB) rating: N/A Trustpilot rating: 3.7 out of 5 stars (based on one review) …

Natural Alternatives International (Nasdaq: NAII) reported fiscal 2026 Q3 net sales of $35.5 million, up 23% year over year, with a net loss of $4.3 million ($0.72/share). Nine‑month sales rose to $108.0 million with a $7.2 million net loss.Private-label manufacturing grew, while CarnoSyn® revenue declined year to date. Management cites factory underutilization for operating losses and expects a full‑year 2026 net loss. A new $11 million term loan and $20 million credit line with Legacy Corporate Lending aim to improve liquidity and flexibility.

Natural Alternatives International (NAII) expanded applications for TriBsyn, its clinically supported carnosine booster, into ready-to-drink beverages, protein drinks, dairy products, gummies, and medical nutrition on May 4, 2026.TriBsyn delivers beta-alanine benefits without paresthesia, supports healthy aging, energy, cognition, and cardiovascular health, is backed by more than 55 clinical studies, and holds New Dietary Ingredient (NDI) status. The ingredient is available to brand partners worldwide.

Natural Alternatives International (NASDAQ: NAII) launched CarnoSyn® 4X on April 20, 2026, a proprietary, patent-pending beta-alanine formulation that delivers more than four times the bioavailability of standard beta-alanine and claims to avoid paresthesia.The ingredient is backed by 55+ clinical studies, retains New Dietary Ingredient (NDI) status, and is available now for sports nutrition brands seeking efficacious dosing and improved user experience.

Natural Alternatives International (Nasdaq: NAII) reported a net loss of $0.3M (‑$0.05 per diluted share) on net sales of $37.7M for Q1 FY2026, versus a net loss of $2.0M on $33.2M a year earlier. Net sales rose 13.8%, driven by a 17.7% increase in private‑label contract manufacturing sales.Gross profit was $4.397M and the company generated income from operations of $0.284M versus an operating loss in the prior year quarter. CarnoSyn revenue declined 33.9% to $1.7M. Cash was $7.7M and working capital was $31.2M as of Sept 30, 2025; $2.5M was outstanding on a $10.0M credit facility. Management expects a net loss in H1 FY2026 and net income in H2 and for the full year.

Natural Alternatives International (NASDAQ: NAII), a nutritional supplements manufacturer, reported a challenging Q4 fiscal 2025 with a net loss of $7.2 million ($1.20 per share), compared to a $1.9 million loss in Q4 2024. The quarter included non-recurring charges of $1.4 million for litigation settlement and a $4.8 million tax asset valuation allowance.Despite challenges, Q4 net sales increased 15% to $33.9 million, with private-label manufacturing up 15% to $31.8 million and CarnoSyn® revenue up 14% to $2.1 million. For full fiscal 2025, net sales grew 14% to $129.9 million, though the company recorded a net loss of $13.6 million.Looking ahead, management forecasts significant sales growth and expects to achieve profitability in the second half of fiscal 2026. As of June 30, 2025, NAII maintained $12.3 million in cash and $30.5 million in working capital.

Natural Alternatives International (NAII) reported its Q3 2025 financial results with mixed performance. The company posted a net loss of $2.2 million ($0.37 per share) on net sales of $28.8 million, compared to a loss of $1.6 million in Q3 2024. While total sales increased 14% year-over-year, driven by a 20% growth in private-label contract manufacturing to $27.1 million, CarnoSyn® beta-alanine revenue declined 36% to $1.7 million. For the nine months ended March 31, 2025, net sales grew 14% to $96.0 million, but net losses widened to $6.4 million. The company faced challenges from factory underutilization, increased operating expenses, and higher manufacturing costs. As of March 31, 2025, NAII had $10.6 million in cash and working capital of $35.2 million, with $8.5 million available on its credit facility.

CarnoSyn for fallen angels

WARNING: C4 Performance Energy® is made for athletes.Whether you’re battling for rings or playing for pride, C4 Performance Energy® contains clinically studied ingredients that enhance performance at every stage of the game. Each can is powered by 200mg of caffeine and CarnoSyn® Beta-Alanine for explosive energy and enhanced endurance.*Side effects may include shattered PRs and total confidence that your product is free of sugar, artificial colors, and 290+ banned substances. Drink at your own risk of excellence.

C4 Energy officially entered the energy shot category with the launch of C4 Performance Energy Sh...